Document is current

Gene therapy for ADA‐SCID, the first marketing approval of an <i>ex vivo</i> gene therapy in Europe: paving the road for the next generation of advanced therapy medicinal products

Crossref DOI link: https://doi.org/10.15252/emmm.201707573

Published Online: 2017-04-10

Published Print: 2017-06

Update policy: https://doi.org/10.1002/crossmark_policy